|
NEW YORK and LONDON, March 22, 2023 /PRNewswire/ - - Huma Therapeutics ("Huma"), a leading global digital health company, today announced that it has become the only company in the world to receive EU MDR 2017/745 Class IIb certification for a disease ...
Adnkronos
-
23-3-2023
|
|
|
|
LONDON, Feb. 8, 2023 /PRNewswire/ - - Huma Therapeutics ("Huma"), a leading global digital health company, today announced a partnership with Camden Health Partners and UCLPartners to deliver a digital - first programme aimed at ...
Adnkronos
-
8-2-2023
|
|
|
|
1, 2023 /PRNewswire/ - - Huma Therapeutics Limited ("Huma"), a leading global digital health company, and Bayer, a leading global life sciences company, have partnered to develop the Bayer Aspirin ...
Adnkronos
-
1-2-2023
|
|
|
|
LONDON, Jan. 13, 2023 /PRNewswire/ - - Huma Therapeutics Limited ("Huma"), a leading global digital health company, today announced results of a new study in collaboration with the Medical Research Council Epidemiology Unit at the ...
Adnkronos
-
13-1-2023
|
|
|
|
LONDON and FRANKFURT, Germany, Jan. 9, 2023 /PRNewswire/ - - Huma Therapeutics Limited ("Huma"), a leading global digital health company, today announced that it has acquired Alcedis GmbH ("Alcedis"), a market - leader for data driven clinical research and ...
Adnkronos
-
9-1-2023
|
|
|
|
|
|
